{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:17:59Z","timestamp":1784305079981,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.leukres.2022.107006","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T11:01:27Z","timestamp":1672052487000},"page":"107006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study"],"prefix":"10.1016","volume":"125","author":[{"given":"Arnaud","family":"Lesegretain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahmane","family":"Laadem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Fell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir T.","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ajcp\/aqaa046","article-title":"How I diagnose low-grade myelodysplastic syndromes","volume":"154","author":"Siddon","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2022.107006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2018.09.001","article-title":"Epidemiology of myelodysplastic syndromes: why characterizing the beast is a prerequisite to taming it","volume":"34","author":"Zeidan","year":"2019","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.leukres.2022.107006_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/2159-8290.CD-20-1579","article-title":"Poor survival and differential impact of genetic features of Black patients with acute myeloid leukemia","volume":"11","author":"Bhatnagar","year":"2021","journal-title":"Cancer Disco"},{"issue":"15","key":"10.1016\/j.leukres.2022.107006_bib4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"issue":"961","key":"10.1016\/j.leukres.2022.107006_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/pgmj.2005.032813","article-title":"Access and equity to cancer care in the USA: a review and assessment","volume":"81","author":"Siminoff","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.leukres.2022.107006_bib6","unstructured":"American Cancer Society, Cancer Facts & Figures for African Americans 2019\u20132021, 2019. \u3008https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-facts-and-figures-for-african-americans\/cancer-facts-and-figures-for-african-americans-2019\u20132021.pdf\u3009. (Accessed August 8, 2022)."},{"key":"10.1016\/j.leukres.2022.107006_bib7","unstructured":"American Society of Hematology, Message from the ASH President on Diversity, Equity, and Inclusion., 2020. \u3008https:\/\/www.hematology.org\/newsroom\/press-releases\/2020\/message-from-the-ash-president-on-diversity-equity-and-inclusion\u3009. (Accessed September 2, 2020)."},{"issue":"17","key":"10.1016\/j.leukres.2022.107006_bib8","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1200\/JCO.2008.21.1680","article-title":"American society of clinical oncology policy statement: disparities in cancer care","volume":"27","author":"Goss","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2022.107006_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.82","article-title":"Differences in genomic patterns and clinical outcomes between African-American and white patients with myelodysplastic syndromes","volume":"7","author":"Nazha","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2022.107006_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2162-3619-3-22","article-title":"Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort","volume":"3","author":"Sridharan","year":"2014","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2022.107006_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/10428194.2012.710904","article-title":"Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experience","volume":"54","author":"Zandberg","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.leukres.2009.03.022","article-title":"Outcome of patients with myelodysplastic syndromes in the Veterans Administration population","volume":"34","author":"Komrokji","year":"2010","journal-title":"Leuk. Res."},{"issue":"7","key":"10.1016\/j.leukres.2022.107006_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/10428194.2022.2032034","article-title":"The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis","volume":"63","author":"Goksu","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2022.107006_bib14","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database, Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2020 Census Data). \u3008https:\/\/seer.cancer.gov\/registries\/data.html\u3009. (Accessed August 2, 2022)."},{"issue":"12","key":"10.1016\/j.leukres.2022.107006_bib15","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.leukres.2022.107006_bib16","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database, SEER Research Plus Data, 18 Registries, Nov 2020 Sub (2000\u20132018) - Linked To County Attributes - Time Dependent (1990\u20132018) Income\/Rurality, 1969\u20132019 Counties. (Accessed August 2, 2022)."},{"key":"10.1016\/j.leukres.2022.107006_bib17","unstructured":"D. Ruhl, M. Adamo, L. Dickie, S. Negoita, Heamtopoietic and Lymphoid Neoplsam Coding Manual, National Cancer Institute, Bethesda, MD, 2021."},{"issue":"20","key":"10.1016\/j.leukres.2022.107006_bib18","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2022.107006_bib19","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/bloodadvances.2017010165","article-title":"Risk and timing of cardiovascular death among patients with myelodysplastic syndromes","volume":"1","author":"Brunner","year":"2017","journal-title":"Blood Adv."},{"issue":"30","key":"10.1016\/j.leukres.2022.107006_bib20","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2022.107006_bib21","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov\/seerstat) version 8.3.9.2. (Accessed February 15, 2022)."},{"issue":"4","key":"10.1016\/j.leukres.2022.107006_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1536867X0900900402","article-title":"Cem: coarsened exact matching in Stata","volume":"9","author":"Blackwell","year":"2009","journal-title":"Stata J."},{"issue":"2","key":"10.1016\/j.leukres.2022.107006_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"Lindberg, SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2018.05.015","article-title":"The current approach to the diagnosis of myelodysplastic syndromes","volume":"56","author":"Weinberg","year":"2019","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2022.107006_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11899-012-0140-3","article-title":"Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors","volume":"7","author":"Steensma","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"10","key":"10.1016\/j.leukres.2022.107006_bib26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood-2018-10-844670","article-title":"MDS overlap disorders and diagnostic boundaries","volume":"133","author":"Tanaka","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000489042","article-title":"ICUS, IDUS, CHIP and CCUS: diagnostic criteria, separation from MDS and clinical implications","volume":"86","author":"Valent","year":"2019","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2014.09.010","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS","volume":"36","author":"Valent","year":"2012","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00277-012-1565-4","article-title":"Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification","volume":"92","author":"Font","year":"2013","journal-title":"Ann. Hematol."},{"issue":"17","key":"10.1016\/j.leukres.2022.107006_bib30","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1182\/blood-2011-03-342642","article-title":"Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers","volume":"118","author":"Naqvi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.107006_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.23","article-title":"Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment","volume":"6","author":"Gangat","year":"2016","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.leukres.2012.09.021","article-title":"Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts","volume":"37","author":"Maassen","year":"2013","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.leukres.2022.107006_bib33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.49.8.664","article-title":"Ethnic and sex differences in the total and differential white cell count and platelet count","volume":"49","author":"Bain","year":"1996","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.2020008600","article-title":"When non-Whiteness becomes a condition","volume":"137","author":"Merz","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.107006_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000360","article-title":"Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene","volume":"5","author":"Reich","year":"2009","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.leukres.2022.107006_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamainternmed.2021.3108","article-title":"Association between a common, benign genotype and unnecessary bone marrow biopsies among African American patients","volume":"181","author":"Van Driest","year":"2021","journal-title":"JAMA Intern. Med"},{"issue":"2","key":"10.1016\/j.leukres.2022.107006_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/blood-2005-02-0713","article-title":"Hematologic differences between African-Americans and whites: the roles of iron deficiency and \u03b1-thalassemia on hemoglobin levels and mean corpuscular volume","volume":"106","author":"Beutler","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2022.107006_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jn\/122.7.1417","article-title":"Iron nutrition does not account for the hemoglobin differences between blacks and whites","volume":"122","author":"Perry","year":"1992","journal-title":"J. Nutr."},{"issue":"5","key":"10.1016\/j.leukres.2022.107006_bib39","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3390\/ijms22052595","article-title":"Sex-related differences in chronic myeloid neoplasms: from the clinical observation to the underlying biology","volume":"22","author":"Karantanos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.leukres.2022.107006_bib40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/10428194.2016.1246726","article-title":"Clinical research consortium, differential response to hypomethylating agents based on sex: a report on behalf of the MDS clinical research consortium (MDS CRC)","volume":"58","author":"DeZern","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2022.107006_bib41","doi-asserted-by":"crossref","unstructured":"H. D\u00f6hner, A.H. Wei, F.R. Appelbaum, C. Craddock, C.D. DiNardo, H. Dombret, B.L. Ebert, P. Fenaux, L.A. Godley, R.P. Hasserjian, R.A. Larson, R.L. Levine, Y. Miyazaki, D. Niederwieser, G.J. Ossenkoppele, C. R\u00f6llig, J. Sierra, E.M. Stein, M.S. Tallman, H.F. Tien, J. Wang, A. Wierzbowska, B. L\u00f6wenberg, Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel, Blood 2022 Jul 7:blood.2022016867. doi: \u300810.1182\/blood.2022016867\u3009. Epub ahead of print.","DOI":"10.1182\/blood.2022016867"},{"issue":"5","key":"10.1016\/j.leukres.2022.107006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6705a1","article-title":"Heart disease death rates among blacks and whites aged >\/=35 years - United States, 1968-2015","volume":"67","author":"Van Dyke","year":"2018","journal-title":"MMWR Surveill. Summ."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:22Z","timestamp":1758935002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622003824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S0145212622003824"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107006"}}